Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals Day
03 Maio 2023 - 5:00PM
Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ:
DRTS, DRTSW), the developer of the innovative alpha-radiation
cancer therapy Alpha DaRT™, today announced that Raphi Levy, Chief
Financial Officer, will take part in a fireside chat at the
Guggenheim Radiopharmaceuticals Day in New York City on Monday, May
15th, 2023.
Event: |
Guggenheim Radiopharmaceuticals Day |
Date: |
Monday, May 15th, 2023 |
Time: |
11:20 AM ET |
Location: |
New York, NY |
Webcast: |
Link |
Mr. Levy will also be available for 1x1 investor meetings at the
conference. Please reach out to your Guggenheim representative to
schedule.
About Alpha Tau Medical, Ltd.Founded in 2016,
Alpha Tau is an Israeli medical device company that focuses on
research, development, and potential commercialization of the Alpha
DaRT for the treatment of solid tumors. The technology was
initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari
from Tel Aviv University.
Investor Relations Contact:IR@alphatau.com
Alpha Tau Medical (NASDAQ:DRTSW)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Alpha Tau Medical (NASDAQ:DRTSW)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024